Target intelligence / Profile preview

Fatty acid–sensing G protein–coupled receptor

Molecular classification
G protein–coupled receptor, Receptor
01

Overview

Fatty acid–sensing G protein–coupled receptors (GPCRs), sometimes called free fatty acid receptors (FFARs) or lipid-sensing GPCRs, are a subgroup of cell-surface receptors that detect extracellular free fatty acids and initiate intracellular signaling responses[1][2][4]. This family includes several distinct GPCRs—most notably GPR40 (FFAR1), GPR41 (FFAR3), GPR43 (FFAR2), GPR84, GPR119, and GPR120 (FFAR4)—which differ in fatty acid chain-length specificity, tissue localization, and biological roles[1][2]. These receptors regulate immune responses, metabolic signaling, and inflammation[1][2][3][4]. Dysregulation or targeting of these receptors is implicated in obesity, type 2 diabetes, atherosclerosis, and inflammatory diseases[1][3][4]. Each molecular subtype is studied individually as a potential therapeutic target, especially for metabolic diseases, but "fatty acid–sensing GPCR" as a class is a descriptive group rather than a single drug target.

Other names
Fatty acid receptorLipid-sensing GPCRFree fatty acid receptorFFAR
02

Mechanism of action

Ligand (fatty acid)-induced activation of intracellular signaling pathways, notably via G proteins such as Gq/11[3]. Modulation of PI3K/Akt pathway leading to glucose uptake[3].

03

Biological functions

Signal transductionImmune responseMetabolic regulationInflammation controlGlucose uptake
04

Disease associations

ObesityType 2 diabetesMetabolic diseaseInflammationCardiovascular diseaseAsthmaHepatic steatosisInflammatory bowel diseases
05

Safety considerations

Potential effects on systemic metabolismImmune modulationUnknown long-term safety for drugs targeting the whole class
06

Interacting drugs

No specific approved drugs named for the whole class; individual receptors like GPR120 are under investigation as therapeutic targets for metabolic diseases[1][3].
07

Biomarkers

No standard biomarkers identified for the entire class; may include signaling molecules or gene expression regulated by receptor activation in adipose or immune cells.

Beyond the preview

Go deeper on Fatty acid–sensing G protein–coupled receptor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fatty acid–sensing G protein–coupled receptor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call